MedTrace Logo

Efficacy and Safety Study of Two Propofol Formulations

NCT00506246 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2008-02-25

No results posted yet for this study

Summary

The purpose of the study to compare Propofol-MCT/LCT with LCT in terms of their efficacy and safety during total intravenous anaesthesia

Conditions

  • General Anaesthesia
  • Induction of Anaesthesia

Interventions

DRUG

Propofol

* intravenous (total intravenous anaesthesia) * induction and maintenance

Sponsors & Collaborators

  • B. Braun Medical International Trading Company Ltd.

    collaborator INDUSTRY

  • Tigermed Consulting Co., Ltd

    collaborator INDUSTRY

  • B. Braun Melsungen AG

    lead INDUSTRY

Principal Investigators

  • Zhanggang Xue, Prof · Shanghai Zhongshan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00506246 on ClinicalTrials.gov